Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1251724

Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection

Sulicka-Grodzicka, Joanna; Surdacki, Andrzej; Surmiak, Marcin; Sanak, Marek; Wizner, Barbara; Sydor, Wojciech; Bociąga-Jasik, Monika; Strach, Magdalena; Korkosz, Mariusz; Skladany, Lubomir et al.
Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection // Biomedicines, 10 (2022), 10; 2462, 14 doi:10.3390/biomedicines10102462 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 1251724 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection

Autori
Sulicka-Grodzicka, Joanna ; Surdacki, Andrzej ; Surmiak, Marcin ; Sanak, Marek ; Wizner, Barbara ; Sydor, Wojciech ; Bociąga-Jasik, Monika ; Strach, Magdalena ; Korkosz, Mariusz ; Skladany, Lubomir ; Grgurevic, Ivica ; Podrug, Kristian ; Kukla, Michał

Izvornik
Biomedicines (2227-9059) 10 (2022), 10; 2462, 14

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
chemerin ; resistin ; pentraxin 3 ; adipokines ; SARS-CoV2 ; specialized-pro-resolving mediators ; inflammation

Sažetak
Chemerin is one of the specialized pro-resolving mediators that participate in the early phase of inflammation and contribute to the initiation of the pro-resolving response. There is a paucity of data regarding the time course of chemerin during acute infections. We aimed to evaluate the sequence of inflammatory responses in the acute COVID-19 phase throughout onset and resolution of inflammation. We evaluated changes in selected biomarkers in COVID-19 survivors on the 7-day and 28-day follow up. Chemerin was lower in patients with baseline moderate/severe disease at day 7 compared with asymptomatic patients and individuals with mild illness (7265 [5526-9448] vs. 8730 [6888-11, 058] pg/mL ; p = 0.03). Only in patients with moderate/severe disease, but not in those with mild symptoms, were chemerin concentrations decreased one week after infection onset compared with baseline (7265 [5526-9448] vs. 8866 [6383-10, 690] pg/mL ; p < 0.05) with a subsequent increase on the 28-day follow up (9313 [7353-11, 033] pg/mL ; p < 0.05). Resolution of inflammation in the group of moderate/severe SARS- CoV2 infection was associated with increasing serum concentrations of chemerin, contrary to pro- inflammatory cytokines and adipokines (pentraxin 3, TNF alpha, resistin, leptin). A similar pattern of angiopoietin-2 dynamics may suggest signs of enhanced vascularization as a consequence of acute SARS-CoV2 infection.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
KBC Split,
Medicinski fakultet, Split

Profili:

Avatar Url Ivica Grgurević (autor)

Poveznice na cjeloviti tekst rada:

doi www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Sulicka-Grodzicka, Joanna; Surdacki, Andrzej; Surmiak, Marcin; Sanak, Marek; Wizner, Barbara; Sydor, Wojciech; Bociąga-Jasik, Monika; Strach, Magdalena; Korkosz, Mariusz; Skladany, Lubomir et al.
Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection // Biomedicines, 10 (2022), 10; 2462, 14 doi:10.3390/biomedicines10102462 (međunarodna recenzija, članak, znanstveni)
Sulicka-Grodzicka, J., Surdacki, A., Surmiak, M., Sanak, M., Wizner, B., Sydor, W., Bociąga-Jasik, M., Strach, M., Korkosz, M. & Skladany, L. (2022) Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection. Biomedicines, 10 (10), 2462, 14 doi:10.3390/biomedicines10102462.
@article{article, author = {Sulicka-Grodzicka, Joanna and Surdacki, Andrzej and Surmiak, Marcin and Sanak, Marek and Wizner, Barbara and Sydor, Wojciech and Boci\k{a}ga-Jasik, Monika and Strach, Magdalena and Korkosz, Mariusz and Skladany, Lubomir and Grgurevic, Ivica and Podrug, Kristian and Kukla, Micha\l}, year = {2022}, pages = {14}, DOI = {10.3390/biomedicines10102462}, chapter = {2462}, keywords = {chemerin, resistin, pentraxin 3, adipokines, SARS-CoV2, specialized-pro-resolving mediators, inflammation}, journal = {Biomedicines}, doi = {10.3390/biomedicines10102462}, volume = {10}, number = {10}, issn = {2227-9059}, title = {Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection}, keyword = {chemerin, resistin, pentraxin 3, adipokines, SARS-CoV2, specialized-pro-resolving mediators, inflammation}, chapternumber = {2462} }
@article{article, author = {Sulicka-Grodzicka, Joanna and Surdacki, Andrzej and Surmiak, Marcin and Sanak, Marek and Wizner, Barbara and Sydor, Wojciech and Boci\k{a}ga-Jasik, Monika and Strach, Magdalena and Korkosz, Mariusz and Skladany, Lubomir and Grgurevic, Ivica and Podrug, Kristian and Kukla, Micha\l}, year = {2022}, pages = {14}, DOI = {10.3390/biomedicines10102462}, chapter = {2462}, keywords = {chemerin, resistin, pentraxin 3, adipokines, SARS-CoV2, specialized-pro-resolving mediators, inflammation}, journal = {Biomedicines}, doi = {10.3390/biomedicines10102462}, volume = {10}, number = {10}, issn = {2227-9059}, title = {Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection}, keyword = {chemerin, resistin, pentraxin 3, adipokines, SARS-CoV2, specialized-pro-resolving mediators, inflammation}, chapternumber = {2462} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.